|
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) |
|
Arrowhead Pharmaceuticals Inc
ARWR's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Arrowhead Pharmaceuticals Inc 's sales fell
by -29.6 % in I. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 2.68 %
Arrowhead Pharmaceuticals Inc net loss increased from $-135 millions, to $-175 millions in I. Quarter 2024,
• More on ARWR's Growth
|
|
Arrowhead Pharmaceuticals Inc realized a net loss in trailing twelve months.
Arrowhead Pharmaceuticals Inc realized cash reduction of $ -0.07 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 943.35.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.42.
• More on ARWR's Valuation
|
|
|
|
|
Arrowhead Pharmaceuticals Inc realized net loss in trailing twelve months.
Arrowhead Pharmaceuticals Inc realized cash outflow of $ -0.07per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 943.35.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.42.
Arrowhead Pharmaceuticals Inc Price to Book Ratio is at 42.06 lower than Industry Avg. of 82.31. and higher than S&P 500 Avg. of 0.02
• More on ARWR's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com